Skip to main content
SpringerLink
Log in

Parental Reporting of Adverse Drug Reactions Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Medications in Children Attending Specialist Paediatric Clinics in the UK

  • Original Research Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Background: The development of systems to ensure appropriate and informed use of medicines in children is a global priority. Current pharmacovigilance systems, such as the UK Yellow Card Scheme, are limited by opportunistic reporting of adverse drug reactions (ADRs), lack of a denominator and lower than expected reporting rates.

Objective: To develop a pharmacovigilance system able to target specific patient populations such as children, and specific medicines of interest, using specialist medical clinics.

Methods: Between January and March 2010, parents of 578 children (3–16 years of age) receiving pharmacological therapy for attention-deficit hyperactivity disorder and attending a child and adolescent clinic in the UK were sent an ADR questionnaire to elicit information on possible ADRs associated with their child’s medication use. Two approaches, free text and a symptom tick list, were used to elicit possible ADRs.

Results: Two hundred and seven questionnaires were returned, of which 200 were evaluable, giving a response rate of 35.9%. 123 questionnaires reported a total of 213 free-text ADRs perceived by the parents to be due to the medications under study. Two-thirds of reported ADRs were considered to be ongoing at the time of reporting. Duration of reported ADRs ranged from 1 week to 3 years. 81 returned questionnaires reported 134 different ADRs for methylphenidate monotherapy. For methylphenidate, the most frequently reported ADRs were loss of appetite (34.3%), headache (17.9%), mood and emotional problems (14.9%), stomach upset (14.9%), sleep disturbance (10.4%), and rash and other skin problems (5.2%). 467 possible drug-related symptoms were reported using the tick-list approach. Using the tick list, the most frequently reported symptoms were mood and emotional problems (28.1% [131/467]), stomach and abdominal problems (13.3% [62/467]), insomnia (12.8% [60/467]) and lack of appetite (12.6% [59/467]). The symptom tick list identified a broader range of possible adverse effects not reported as free-text ADRs, such as schooling difficulties, hearing problems, cough and blurred vision.

Conclusions: The results of our study demonstrate the feasibility of using specialist clinics to target both at-risk patient populations and/or medicines of interest. We have also clearly demonstrated the practicality and feasibility of parental reporting. Parents reported common and less common ADRs, such as suicidal ideation, using both the free text and symptom tick-list approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Table II
Table III

Similar content being viewed by others

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994

    Google Scholar 

  2. Ford T, Goodman R, Meltzer H. The British child and adolescent mental health survey 1999: the prevalence of DSM-IV disorders. J Am Acad Child Adolesc Psychiatry 2003; 42: 1203–11

    Article  PubMed  Google Scholar 

  3. NHS. ADHD: services over Scotland. Report of the service profiling exercise. March 2007 [online]. Available from URL: http://www.nhshealthquality.org/nhsqis/files/ADHD_ServicesOverScotland_MAR07.pdf [Accessed 2009 Nov 13]

  4. Ross C, Davies P, Whitehouse W. Melatonin treatment for sleep disorders in children with neuro developmental disorders: an observational study. Dev Med Child Neurol 2002; 4: 339–44

    Google Scholar 

  5. Meijer WM, Faber A, den Ban EV, et al. Current issues around the pharmacotherapy of ADHD in children and adults. Pharm World Sci 2009; 31: 509–16

    Article  PubMed  Google Scholar 

  6. Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child 2005; 90 Suppl.: i2-7

    Google Scholar 

  7. Lerner M, Wigal T. “Long-term safety of stimulant medications used to treat children with ADHD”. Pediatr Ann 2008; 37(1): 37–45

    Article  PubMed  Google Scholar 

  8. BMA. Reporting adverse drug reactions: a guide for healthcare professionals. London: BMA, 2006 May [online]. Available from URL: http://www.bma.org.uk/images/ADRFinal_tcm41-20713.pdf. [Accessed 2009 Dec 16]

    Google Scholar 

  9. Goldman SA. Limitations and strengths of spontaneous reports data. Clin Ther 1998; 20 Suppl. C: C40-4

    Google Scholar 

  10. Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 2002; 54(6): 665–70

    Article  PubMed  Google Scholar 

  11. Mosholder AD, Gelperin K, Hammad TA, et al. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children. Pediatrics 2009; 123: 611–6

    Article  PubMed  Google Scholar 

  12. Tobaiqy M, Bond C, Helms P, et al. A pilot study to evaluate a community pharmacy based monitoring system to identify adverse drug reactions associated with paediatric medicines use. Eur J Clin Pharmacol 2010; 66(6): 627–32

    Article  PubMed  CAS  Google Scholar 

  13. Stewart D, Helms PJ, Bond CM, et al. Monitoring adverse drug reactions in children using community pharmacies: a pilot study. Br J Clin Pharmacol 2005; 59: 677–83

    Article  PubMed  Google Scholar 

  14. Tobaiqy M, Stewart D, Helms PJ, et al. Views of parents and pharmacists following participation in a paediatric pharmacovigilance study. Pharm World Sci 2010; 32(3): 334–8

    Article  PubMed  Google Scholar 

  15. Wallin J, Sjovall J. Detection of adverse drug reactions in a clinical trial using two types of questioning. Clin Ther 1981; 3: 450–2

    PubMed  CAS  Google Scholar 

  16. Wallander MA, Dimenas E, Svardsudd K, et al. Evaluation of three methods of symptom reporting in a clinical trial of felodipine. Eur J Clin Pharmacol 1991; 41: 187–96

    Article  PubMed  CAS  Google Scholar 

  17. Bent S, Padula A, Avins LA. Brief communication: better ways to question patients about adverse medical events: a randomized, controlled trial. Ann Intern Med 2006 Feb; 144: 257–61

    PubMed  Google Scholar 

  18. Graham J, Coghill D. Adverse effects of pharmaco-therapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management. CNS Drugs 2008; 22(3): 213–37

    Article  PubMed  CAS  Google Scholar 

  19. Lucas AR, Weiss M. Methylphenidate hallucinosis. JAMA 1971; 217: 1079–81

    Article  PubMed  CAS  Google Scholar 

  20. Bloom AS, Russell LJ, Weisskopf B, et al. Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 1988; 27: 88–9

    Article  PubMed  CAS  Google Scholar 

  21. Cherland E, Fitzpatrick R. “Psychotic side effects of psychostimulants: a 5-year review” (PDF). Can J Psychiatry 1999; 44(8): 811–3

    PubMed  CAS  Google Scholar 

  22. Safer D, Allen R, Barr E. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 1997; 100(4): 662–6

    Article  Google Scholar 

  23. Golinko B. Side effects of dextroamphetamine and methylphenidate in hyperactive children: a brief review. Prog Neuropsychopharmacol Biol Psychiatry 1984; 8: 1–8

    Article  PubMed  CAS  Google Scholar 

  24. Faraone SV, Biederman J, Morley CP, et al. Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 2008; 47(9): 994–1009

    PubMed  Google Scholar 

  25. Vitiello B. Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2001; 11: 25–34

    Article  PubMed  CAS  Google Scholar 

  26. The Electronic Medicines Compendium. Concerta XL: summary of product characteristics (SPC) [online]. Available from URL: http://www.medicines.org.uk/EMC/searchresults.aspx?term=methylphenidate&searchtype=QuickSearch [Accessed 2009 Nov 13]

  27. MHRA. Download Drug Analysis Prints (DAPs) [online]. Available from URL: http://www.mhra.gov.uk/home/groups/public/documents/sentineldocuments/dap_1293013819922.pdf [Accessed 2009 Nov 13]

  28. Consumers’ adverse medicine events line [online]. Available from URL: http://www.nps.org.au/consumers/publications/medicines_talk/mt8/consumers_adverse_medicines_events_line [Accessed 2010 Feb 7]

Download references

Acknowledgements

We would like to thank Dr Carol Gilmour, all clinic and medical staff, and respondents who took part in the research. No sources of funding were used to prepare this manuscript. None of the authors have any conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Division of Applied Health Sciences, The Aberdeen School of Medicine and Dentistry, University of Aberdeen, Aberdeen, 24 3FX, UK

    Mansour Tobaiqy, PeterJ. Helms, Justin Williams &  James McLay

  2. School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK

    Derek Stewart

  3. Royal Aberdeen Children’s Hospital, Aberdeen, UK

    Jackie Crum

  4. Paediatric Unit, Victoria Hospital, Kirkcaldy, Fife, UK

    Christopher Steer

Authors
  1. Mansour Tobaiqy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Derek Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. PeterJ. Helms
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Justin Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jackie Crum
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christopher Steer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. James McLay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James McLay.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tobaiqy, M., Stewart, D., Helms, P. et al. Parental Reporting of Adverse Drug Reactions Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Medications in Children Attending Specialist Paediatric Clinics in the UK. Drug-Safety 34, 211–219 (2011). https://doi.org/10.2165/11586050-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11586050-000000000-00000

Keywords

Search

Navigation